
==== Front
Eur Psychiatry
Eur Psychiatry
EPA
European Psychiatry
0924-9338
1778-3585
Cambridge University Press Cambridge, UK

10.1192/j.eurpsy.2021.2238
S0924933821022380
Corrigendum
Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study – CORRIGENDUM
Olivares José Manuel
González-Pinto Ana
Páramo Mario
on behalf of the PROSIGO Study Group
2021
11 10 2021
11 10 2021
64 1 e59© The Author(s) 2021
2021
The Author(s)
https://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

https://doi.org/10.1192/j.eurpsy.2021.23, Published by Cambridge University Press on behalf of the European Psychiatric Association, 12th April 2021Keywords

schizophrenia
persistence
aripiprazole
antipsychotic
predictors
corrigendum
==== Body
pmcThis article when published failed to include the full list of Dr Ana González-Pinto’s affiliations, which are as follows:Hospital Universitario de Álava, Álava, Spain

CIBERSAM, Biomedical Research Centre in Mental Health Network, Madrid, Spain

Universidad del País Vasco, Álava, Spain

IIS Bioaraba, Álava, Spain
==== Refs
Reference

Olivares JM, González-Pinto A, Páramo M, on behalf of the PROSIGO Study Group (2021). Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study. European Psychiatry, 64 (1 ), e40, 1–13 10.1192/j.eurpsy.2021.23

